Resultado de búsqueda
Continuum: Lifelong Learning in Neurology® is a topic-based self-study continuing medical education publication from the American Academy of Neurology. Continuum is clinically based and written in clear, concise language by experts in the neurology subspecialties.
- Current Issue
Current Issue - CONTINUUM: Lifelong Learning in Neurology -...
- CME
US Participants . The ABPN has reviewed Continuum: Lifelong...
- Past Issues
Past Issues - CONTINUUM: Lifelong Learning in Neurology -...
- Information for Authors
Information for Authors - CONTINUUM: Lifelong Learning in...
- Video Gallery
The first segment shows a 65-year-old woman with mild...
- About AAN
About AAN - CONTINUUM: Lifelong Learning in Neurology - LWW
- Rights and Permissions
Rights and Permissions - CONTINUUM: Lifelong Learning in...
- Subscription Details and Access
Subscription Details and Access - CONTINUUM: Lifelong...
- Current Issue
Continuum: Lifelong Learning in Neurology® is a topic-based self-study continuing medical education publication from the American Academy of Neurology. Continuum is clinically based and written in clear, concise language by experts in the neurology subspecialties.
Continuum: Lifelong Learning in Neurology® is a topic-based self-study continuing medical education publication from the American Academy of Neurology. Continuum is clinically based and written in clear, concise language by experts in the neurology subspecialties.
Continuum: Lifelong Learning in Neurology® is designed to help practicing neurologists stay abreast of advances in the field while simultaneously developing lifelong self-directed learning skills
18 de jun. de 2024 · Gender-affirming hormone therapy interacts with commonly prescribed neurologic medications and increases stroke risk among transfeminine people. Sex hormones and sex chromosomes may play a role in neurodegeneration and disability progression in neuroimmunologic diseases.
CONTRIBUTORS. Anita Valanju Shelgikar, MD, MHPE, FAASM, Guest Editor. Director, Sleep Medicine Fellowship; Clinical Professor, Neurology, University of Michigan School of Medicine, Ann Arbor, Michigan. Relationship Disclosure: Dr Shelgikar has received personal compensation in the range of $10,000 to $49,999 for serving as an offi cer or member ...
1 de mar. de 1994 · Facioscapulohumeral muscular dystrophy (FSHD) is an autosomal-dominant disorder with a characteristic distribution of weakness and variable severity. Prospective, longitudinal data on FSHD are essential for the design of therapeutic trials and in assessment of genetic heterogeneity.
